Citation: C. Ripamonti et F. Fulfaro, Pathogenesis and pharmacological treatment of bone pain in skeletal metastases, Q J NUCL M, 45(1), 2001, pp. 65-77
Authors:
Mercadante, S
Casuccio, A
Fulfaro, F
Groff, L
Boffi, R
Villari, P
Gebbia, V
Ripamonti, C
Citation: S. Mercadante et al., Switching from morphine to methadone to improve analgesia and tolerabilityin cancer patients: A prospective study, J CL ONCOL, 19(11), 2001, pp. 2898-2904
Authors:
Mercadante, S
Casuccio, A
Pumo, S
Fulfaro, F
Citation: S. Mercadante et al., Factors influencing the opioid response in advanced cancer patients with pain followed at home: the effects of age and gender, SUPP CARE C, 8(2), 2000, pp. 123-130
Citation: S. Mercadante et al., The course of symptom frequency and intensity in advanced cancer patients followed at home, J PAIN SYMP, 20(2), 2000, pp. 104-112
Authors:
Mercadante, S
Casuccio, A
Pumo, S
Fulfaro, F
Citation: S. Mercadante et al., Opioid responsiveness-primary diagnosis relationship in advanced cancer patients followed at home, J PAIN SYMP, 20(1), 2000, pp. 27-34
Authors:
Fulfaro, F
Casuccio, A
Ticozzi, C
Ripamonti, C
Citation: F. Fulfaro et al., The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials, PAIN, 78(3), 1998, pp. 157-169